
Kimia Biosciences Ltd Valuation Shifts to Very Attractive Amid Sector Challenges
2026-11-18 08:00:55Kimia Biosciences Ltd has witnessed a marked improvement in its valuation parameters, shifting from an attractive to a very attractive rating. This change reflects a significant recalibration in price-to-earnings and price-to-book value metrics, positioning the micro-cap pharmaceutical firm favourably against its peers and historical benchmarks.
Read More
Kimia Biosciences Ltd Upgraded to Hold as Financial and Technical Trends Improve
2026-11-17 08:12:55Kimia Biosciences Ltd has seen its investment rating upgraded from Sell to Hold following a notable improvement in its financial trend and technical indicators. Despite persistent challenges in sales growth and cash flow, the company’s profitability and valuation metrics have strengthened, prompting a reassessment of its outlook within the Pharmaceuticals & Biotechnology sector.
Read More
Kimia Biosciences Ltd is Rated Strong Sell
2026-10-30 10:10:24Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 27 July 2026, reflecting a reassessment of the company’s outlook. However, all fundamentals, returns, and financial metrics discussed here are based on the stock’s current position as of 30 October 2026, providing investors with the most up-to-date analysis.
Read More
Kimia Biosciences Ltd is Rated Strong Sell
2026-10-19 10:10:22Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 27 July 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 19 October 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Kimia Biosciences Ltd is Rated Strong Sell
2026-10-08 10:10:27Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 27 July 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 08 October 2026, providing investors with the latest perspective on the company’s position.
Read More
Kimia Biosciences Ltd is Rated Strong Sell
2026-09-27 10:10:16Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 27 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 September 2026, providing investors with the latest insights into the company’s performance and outlook.
Read More
Kimia Biosciences Ltd is Rated Strong Sell
2026-09-16 10:10:19Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 27 July 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Kimia Biosciences Ltd is Rated Strong Sell
2026-09-01 10:10:26Kimia Biosciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 27 July 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 01 September 2026, providing investors with the latest comprehensive view of the company’s position.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
14-Nov-2026 | Source : BSENewspaper publication of Unaudited financial results for the Quarter ended 30 September 2026
Results-Unaudited Standalone Financial Result For Quarter Ending 30Th September 2026
13-Nov-2026 | Source : BSEUnaudited Standalone Financial Results for second quarter and half year ended 30th September 2026 along with statement of assets and liabilities and cash flows and Limited Review Report thereon.
Board Meeting Outcome for Outcome Of Board Meeting Held On November 13 2026 (Friday)
13-Nov-2026 | Source : BSEPursuant to Regulation 33 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we have enclosed herewith:
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available